|
|
Volumn , Issue , 2009, Pages 664-672
|
|
Supportive care and chelation therapy in MDS: are we saving lives or just lowering iron?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BENZOIC ACID DERIVATIVE;
DEFEROXAMINE;
ELTROMBOPAG;
FC RECEPTOR;
HEMOPOIETIC GROWTH FACTOR;
HYBRID PROTEIN;
HYDRAZINE DERIVATIVE;
IRON;
IRON CHELATING AGENT;
PYRAZOLE DERIVATIVE;
ROMIPLOSTIM;
THROMBOPOIETIN;
AGED;
ANEMIA;
BLOOD COMPONENT THERAPY;
CHELATION THERAPY;
ECONOMICS;
HUMAN;
IRON OVERLOAD;
MIDDLE AGED;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
MYELODYSPLASTIC SYNDROME;
NEUTROPENIA;
OFF LABEL DRUG USE;
PHLEBOTOMY;
PRACTICE GUIDELINE;
REVIEW;
THROMBOCYTOPENIA;
AGED;
ANEMIA;
BENZOIC ACIDS;
BLOOD COMPONENT TRANSFUSION;
CHELATION THERAPY;
COMBINED MODALITY THERAPY;
DEFEROXAMINE;
HEMATOPOIETIC CELL GROWTH FACTORS;
HUMANS;
HYDRAZINES;
IRON;
IRON CHELATING AGENTS;
IRON OVERLOAD;
MIDDLE AGED;
MYELODYSPLASTIC SYNDROMES;
NEUTROPENIA;
OFF-LABEL USE;
PHLEBOTOMY;
PRACTICE GUIDELINES AS TOPIC;
PYRAZOLES;
RECEPTORS, FC;
RECOMBINANT FUSION PROTEINS;
THROMBOCYTOPENIA;
THROMBOPOIETIN;
|
|
EID: 77949471981
PISSN: None
EISSN: 15204383
Source Type: Journal
DOI: 10.1182/asheducation-2009.1.664 Document Type: Review |
|
Times cited : (29)
|
|
References (40)
|
